All News

Increases in PrEP coverage were associated with reductions in HIV infections, a new study found.

Phase 3 clinical data demonstrate abrocitinib’s efficacy and safety in treating moderate-to-severe atopic dermatitis in adults.

The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.

The FDA issued emergency use authorization of a rapid, point-of-care COVID-19 diagnostic test, developed by Cepheid, that has a detection time of approximately 45 minutes.

There is currently no scientific evidence suggesting that non-steroidal anti-inflammatory drug use could worsen COVID-19 in those infected.

A malaria drug that President Donald Trump said could possibly treat coronavirus disease (COVID-19) is already in short supply, according to ASHP. However, Teva said it will donate millions of tablets to US hospitals.

What new gaps will pharmacists need to fill?

The FDA previously approved sofosbuvir and velpatasvir to treat HCV in adults.

It’s my hope that 2020 is a profession changing year, starting with the schools of pharmacy.

Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.

A CDC analysis of preliminary data suggests that COVID-19 complications can occur in adults of any age.

A study identified significant similarities between SARS-CoV and SARS-CoV-2.

We asked pharmacists from various settings around the country: “Why did you become a pharmacist, and what keeps you motivated?"

A recent study from China found that diarrhea was a prominent symptom among up to half of patients with COVID-19 during the outbreak in Wuhan.

From drug information to patient education, these apps can help you be better at everything that you do.

Dr. Reddy’s Laboratories has launched its ziprasidone mesylate 20 mg/mL for injection, the first generic version of Geodon (Pfizer) for injection. 

A study evaluated the stability of COVID-19 compared with SARS-CoV-1.

When looking to grow business with supplement sales, pharmacists should first educate themselves.

Relieving symptoms and optimizing therapies for allergic rhinitis

President Trump's coronavirus task force urged to tap into the potential of community pharmacies in combatting the coronavirus pandemic. 

Pharmacy managers and educators offer career advice.

On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.

Insurers, physicians, and others are advising patients with chronic conditions to ensure they have more than enough medication on hand. 

A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.

Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.

President Trump and his health advisors announced a 15-day plan to slow the spread of COVID-19.

Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.

A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.